Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
02:36:41 01/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1725 USD | -9.02% |
|
-0.05% | -24.63% |
| Market Cap | 323M 278M 261M 239M 448M 30.77B 452M 3.1B 1.21B 15.6B 1.21B 1.19B 51.66B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 419M 361M 339M 310M 582M 39.91B 586M 4.02B 1.56B 20.24B 1.57B 1.54B 67.01B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.5x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -9.06% | ||
| 1 week | -0.05% | ||
| Current month | +5.12% | ||
| 1 month | +5.12% | ||
| 3 months | -21.84% | ||
| 6 months | -23.73% | ||
| Current year | -24.63% |
| 1 week | 0.17 |  | 0.22 |
| 1 month | 0.16 | | 0.22 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/8/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 9/8/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.02% | -0.05% | -34.94% | -70.02% | 323M | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +1.24% | -3.14% | -17.35% | +448.58% | 25.89B | |
| -0.71% | -10.22% | +0.66% | -16.24% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| -0.01% | -0.05% | +46.64% | +143.50% | 13.49B | |
| Average | -3.06% | -2.15% | +42.12% | +158.21% | 28.23B | |
| Weighted average by Cap. | -2.20% | -3.48% | +47.83% | +144.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.52M 31.48M 28.73M 53.98M 3.7B 54.36M 373M 145M 1.88B 146M 143M 6.22B |
| Net income | - | - |
| Net Debt | 96.08M 82.72M 77.68M 70.9M 133M 9.14B 134M 920M 358M 4.64B 361M 353M 15.35B | 125M 108M 101M 92.2M 173M 11.89B 174M 1.2B 466M 6.03B 469M 459M 19.96B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | USD 0.1725 | -9.02% | 8,269,217 |
| 28/08/26 | USD 0.1896 | +5.84% | 10,430,794 |
| 27/08/26 | USD 0.1791 | +3.55% | 2,417,558 |
| 26/08/26 | USD 0.1730 | -0.52% | 1,262,376 |
| 25/08/26 | USD 0.1739 | +0.82% | 1,936,134 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1896USD
Average target price
1.000USD
Spread / Average Target
+427.43%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
